Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
21 results
D1.16 - Molecular sensitization profiles in house dust mite allergic patients from Valencian Community
D1.18 - Comparative Analysis of Nasal Secretions and Serum Biomarkers in House Dust Mite Allergy: Correlation with Symptoms and Skin Prick Test Results
D1.19 - Contribution of Panallergens to Edible Insect Reactivity in Mite-Sensitized Individuals
D1.20 - Progesterone-Induced Urticaria: Diagnostic and Therapeutic Approach
D1.22 - Molecular Allergen Sensitization Patterns in Cat, Dog and Horse Allergies in Children
D1.23 - Unrestricted Potential: The Role of AMS in Tackling Allergy Labels
D1.24 - Towards risk assessment of peanut sensitised patients based on statistical modelling of 32,500 IgE-macroarray test results
D1.25 - Clinical Characteristics of Chronic Urticaria in Adults Under 45 Years Old with Vitamin D Insufficiency
D2.342 - Changes of MMP-9 and MMP-12 in response of acute viral infection in virtual model of macrophages
D2.343 - Use of IDDA 2.1 score in Common Variable Immunodeficiency (CVID): a single center experience
D2.344 - Unraveling the Mysteries of Chronic Granulomatous Disease: A Case of detected Protein Deficiency Amidst Negative Genetic Screening
D2.345 - Conformations of HVEM engaged in its Trans and Cis interactions are caused by two kinds of post-translational folding
D2.346 - Assessment of the safety of allogenic natural killer cells in the treatment of metastatic colon cancer
D2.347 - Allergen-Specific T Cells to House Dust Mite are absent on the circulation of local allergic rhinitis patients
D2.348 - Clinical Course of Hereditary Angioedema Patients Transitioning off Androgens
D2.349 - Hereditary Angioedema in Bulgaria: an update on patient characteristics and treatment modalities
D2.350 - CVID: the crossroad between immune dysregulation, autoimmunity and cancer
D3.436 - Advancing Equity in Food Allergy Prevention – Insights and Takeaways from CFAAR’s Summit for Advancing Equity in Food Allergy
D3.437 - An EAACI Task Force Initiative for Visualizing Historical Pollen and Spore Calendars in Europe
D3.438 - Advances in Automated Pollen Monitoring in Mediterranean Regions: New Developments from the SYLVA Project in Córdoba (Spain)
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download